Hepatitis B vaccine recombinant - ChironAlternative Names: HBc-NEO
Latest Information Update: 15 Aug 2007
At a glance
- Originator Chiron Corporation
- Class Hepatitis B vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 25 Mar 1999 New profile
- 25 Mar 1999 Preclinical development for Hepatitis B treatment in USA (IM)